SCHEMBL22259331

SCHEMBL22259331

C[S+]([O-])N1CCC(Nc2ncc3cc(C(F)F)c(=O)[nH]c3n2)CC1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ CDK2 P24941 18/20 0.46
▸ CCNE1 P24864 17/20 0.46
▸ CCND1 P24385 15/20 0.46
▸ CDK6 Q00534 15/20 0.46
▸ MAPK14 Q16539 1/20 0.42
▸ CCNA2 P20248 2/20 0.41
▸ CCNT1 O60563 1/20 0.41
▸ CCNE2 O96020 1/20 0.41
▸ RB1 P06400 1/20 0.41
▸ CDK1 P06493 1/20 0.41
▸ CDK4 P11802 1/20 0.41
▸ CCND3 P30281 1/20 0.41
▸ CDK9 P50750 1/20 0.41
▸ MAPK8 P45983 1/20 0.38
▸ MAPK9 P45984 1/20 0.38
▸ MAPK10 P53779 1/20 0.38
▸ CDK7 P50613 1/20 0.36
▸ CCNH P51946 1/20 0.36
▸ MNAT1 P51948 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23341042 0.86 BRD4 (0.45) CDK2CCNE1CCND1CDK6MAPK14
SCHEMBL22259521 0.84 CDK2 (0.46) CDK2CCNE1CCND1CDK6MAPK14
SCHEMBL19868169 0.84 CCNE1 (0.65) CDK2CCNE1CCND1CDK6CCNA2
SCHEMBL23340824 0.83 CDK2 (0.45) CDK2CCNE1CCND1CDK6MAPK14
SCHEMBL19868343 0.82 CCNE1 (0.56) CDK2CCNE1CCND1CDK6CCNA2
SCHEMBL23341029 0.82 CDK2 (0.44) CDK2CCNE1CCND1CDK6MAPK14
SCHEMBL19868307 0.82 CCNE1 (0.58) CDK2CCNE1CCND1CDK6CDK4
SCHEMBL19886131 0.80 MAPK8 (0.55) CDK2CCNE1CCND1CDK6CCNA2
SCHEMBL24670452 0.77 CCNE1 (0.51) CDK2CCNE1CCND1CDK6CCNA2
SCHEMBL26775790 0.72 CRBN (0.33) CDK2CCNE1CCND1CDK6MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020148635-A1 CRYSTALLINE FORM OF A CDK INHIBITOR PFIZER INC. (US) 2020-07-23 — — WO disclosed
Send feedback